No internet connection — showing the saved version of the page.

Apnimed, Inc.

USUSD
← to the screener

Apnimed, Inc. (US:APMD) — Biotechnology: Pharmaceutical Preparations. Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
apnimed.com
Investor relations
ir.apnimed.com/
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Headquarters
CAMBRIDGE
Shares outstanding
41.63 M as of 2026-09-04
Industry (SIC)
Pharmaceutical Preparations
Net income
126 M USD quarter
For the quarter to 30.06.2026
Revenue12.1 M USD
− Expenses23.8 M USD
Net income126 M USD
NAV
−36.69 USD
Balance sheet date30.06.2026
Assets195 M USD
− Liabilities126 M USD
= NAV (equity of the company's shareholders)−176 M USD
= Tangible NAV−176 M USD
Shares4 801 823
NAV per share−36.69 USD
Tangible NAV per share−36.69 USD
Equity is negative: liabilities exceed assets (often because of large share buybacks). P/NAV is not calculated.
NAV history
Balance sheet dateNAVNAV per share
30.06.2026−176 M USD−36.69 USD
31.03.2026−304 M USD−7.31 USD
31.12.2025−373 M USD−77.97 USD
30.06.2025−345 M USD−8.29 USD
31.03.2025−276 M USD−6.64 USD
31.12.2024−249 M USD−5.97 USD
advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksAPMDUSD19.15 -1.74%common stock

Price

US:APMD · USD
up day down dayHover / tap a day — open, close, high and low prices